Literature DB >> 2975012

Differential effects of the selective D2-antagonist raclopride in the nucleus accumbens of the rat on spontaneous and d-amphetamine-induced activity.

R van den Boss1, A R Cools, S O Ogren.   

Abstract

The effect of the D2-antagonist raclopride was investigated in two test situations, which are presumed to involve dopamine (DA) transmission within the nucleus accumbens of the rat. Local injection of d-amphetamine sulphate (10 micrograms/0.5 microliter) produced a marked increase in motor activity, measured as motility, locomotion, and rearing, which was dose- and time-dependently antagonised by local injection of raclopride (0.05-5.0 micrograms/0.5 microliter). After an initial decrease, at low doses (0.05-0.25 microgram/0.5 microliter) an apparent enhancement of the d-amphetamine-induced motor activity appeared, which was most clearly seen with rearing. These lower doses, however, did not induce any clear changes in the exploratory activity in a novel environment (i.e., the second test situation). Only the higher doses used (1.0-5.0 micrograms/0.5 microliter) decreased exploratory activity during the first 5-10 min, also measured as motility, locomotion, and rearing. These data are discussed with respect to the role of D2-receptors within the nucleus accumbens of rats in the motor activity induced by a novel environment and d-amphetamine. Overall, the data underline previous notions that raclopride is a potent antagonist of DA-mediated behaviour.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2975012     DOI: 10.1007/bf00172953

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity.

Authors:  A J Pijnenburg; W M Honig; J A Van der Heyden; J M Van Rossum
Journal:  Eur J Pharmacol       Date:  1976-01       Impact factor: 4.432

2.  Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?

Authors:  B Costall; D H Fortune; S C Hui; R J Naylor
Journal:  Eur J Pharmacol       Date:  1980-05-16       Impact factor: 4.432

3.  Inhibition of d-amphetamine-induced locomotor activity by injection of haloperidol into the nucleus accumbens of the rat.

Authors:  A J Pijnenburg; W M Honig; J M Van Rossum
Journal:  Psychopharmacologia       Date:  1975

4.  Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity.

Authors:  J M Van Ree; G Wolterink
Journal:  Eur J Pharmacol       Date:  1981-06-10       Impact factor: 4.432

5.  Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

Authors:  L Farde; H Hall; E Ehrin; G Sedvall
Journal:  Science       Date:  1986-01-17       Impact factor: 47.728

6.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum.

Authors:  P H Kelly; P W Seviour; S D Iversen
Journal:  Brain Res       Date:  1975-09-05       Impact factor: 3.252

7.  Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.

Authors:  S O Ogren; H Hall; C Köhler; O Magnusson; L O Lindbom; K Angeby; L Florvall
Journal:  Eur J Pharmacol       Date:  1984-07-20       Impact factor: 4.432

8.  Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.

Authors:  O Magnusson; C J Fowler; C Köhler; S O Ogren
Journal:  Neuropharmacology       Date:  1986-02       Impact factor: 5.250

9.  Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats.

Authors:  B Ellenbroek; M Schwarz; K H Sontag; R Jaspers; A Cools
Journal:  Brain Res       Date:  1985-10-14       Impact factor: 3.252

10.  Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.

Authors:  C Köhler; A C Radesäter
Journal:  Neurosci Lett       Date:  1986-05-06       Impact factor: 3.046

View more
  5 in total

1.  D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell.

Authors:  B Kalyanasundar; Claudia I Perez; Alvaro Luna; Jessica Solorio; Mario G Moreno; David Elias; Sidney A Simon; Ranier Gutierrez
Journal:  J Neurophysiol       Date:  2015-05-13       Impact factor: 2.714

2.  Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc.

Authors:  Stephan Steidl; Shannon O'Sullivan; Dustin Pilat; Nancy Bubula; Jason Brown; Paul Vezina
Journal:  Behav Brain Res       Date:  2017-06-27       Impact factor: 3.332

3.  Simultaneous assessment of rodent behavior and neurochemistry using a miniature positron emission tomograph.

Authors:  Daniela Schulz; Sudeepti Southekal; Sachin S Junnarkar; Jean-François Pratte; Martin L Purschke; Sean P Stoll; Bosky Ravindranath; Sri Harsha Maramraju; Srilalan Krishnamoorthy; Fritz A Henn; Paul O'Connor; Craig L Woody; David J Schlyer; Paul Vaska
Journal:  Nat Methods       Date:  2011-03-13       Impact factor: 28.547

4.  Genetic Disruption of Arc/Arg3.1 in Mice Causes Alterations in Dopamine and Neurobehavioral Phenotypes Related to Schizophrenia.

Authors:  Francesca Managò; Maddalena Mereu; Surjeet Mastwal; Rosa Mastrogiacomo; Diego Scheggia; Marco Emanuele; Maria A De Luca; Daniel R Weinberger; Kuan Hong Wang; Francesco Papaleo
Journal:  Cell Rep       Date:  2016-08-11       Impact factor: 9.423

5.  Towards a reconceptualization of striatal interactions between glutamatergic and dopaminergic neurotransmission and their contribution to the production of movements.

Authors:  Hélène N David
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.